Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Aortech International Plc LSE:AOR London Ordinary Share GB0033360586 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 126.50 123.00 130.00 0.00 0.00 - 0.00 01:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.5 -0.6 -4.7 - 20

Aortech Share Discussion Threads

Showing 8626 to 8650 of 8900 messages
Chat Pages: 356  355  354  353  352  351  350  349  348  347  346  345  Older
DateSubjectAuthorDiscuss
12/5/2020
11:00
Langland, (post 3414) that is my understanding but TAVI is one for up the road. I believe the Elast-Eon polymers are well capable of being adapted for trans-catheter.
bones
12/5/2020
10:49
Net, that’s what I call a half-hearted approach to investing!
bones
12/5/2020
10:43
I decided to bank about 1/2 and take profit. I could have sold a lot higher (oh well) but now its got this low I'd would rather not sell a lot lower - LOL. Anyway still got half. Should have done this a while back. Thanks everyone for this "tip" it has made me a nice bit of cash! (I came in a while back in 40s) Thank you.
netcurtains
12/5/2020
10:37
Interesting comments. As it happens I have been looking at the Edwards website this AM looking at its history and videos of its transcatheter heart valve. It's a sad life I lead. Bones will put me right but RUA/AOR are not aiming for transcatheter at this stage?
langland
12/5/2020
09:35
Agreed GR. Along with news that the newly designed machinery pumps out beautifully formed prototype polymeric heart valves by the boatload. Might be a while for the results of that one to appear but we were last informed (RNS 14th April 2020) that the company “...anticipate manufacturing trials to commence during May 2020.”
bones
12/5/2020
09:15
Design freeze on the textiles and confirmation of moving into testing should stop the current share price drift and give some renewed momentum imo.
greedy rooster
11/5/2020
11:46
Impressive list of Med-Tech companies, Langland. How is Aortech, with all the potential under development, only sitting at a market cap of £12M?? At some point, the light bulb will surely shine bright for one of these Medtechs!
bones
10/5/2020
18:40
Yes I realise this is all standard kit so no retraining is required. My point was whether this platform with its haptic technology could demonstrate remotely the 'surgical feel' of the new products during this time of global lockdown. If surgical feel had not been mentioned in the last RNS, I would not have raised the issue.
langland
10/5/2020
17:52
All of the productsRUA/Aortech are working on require no change in surgical technique and no specialist training will be required.
landy90
10/5/2020
17:16
While we wait for news of (hopefully) a resumption of RUA's core business, the R and D function has no doubt been working on the patches and grafts as well as the HV project. So, while I have till now taken as read that there is a market for these products I had not realised till recently quite how big the medtech world is. So here is a link to the top 40 global medtech companies..... https://www.mddionline.com/top-40-medical-device-companies It's quite a list. Presumably within this list are RUA/AOR's customers and potential customers and potential acquirers. RUA/AOR would be small change to one of these corporations. I am indirectly a shareholder in Fundamental Surgery (through my holding in TERN PLC) and it had occurred to me that its platform could be a vehicle for demonstrating RUA/AOR's products more readily. I am particularly mindful of the paragraph in the last RNS.....'Regulatory testing of the new graft is still anticipated in the second half of this year and the animal trials, in particular, are designed to demonstrate the grafts' performance targets of providing good surgical feel ......'FS's platform is the future for surgical training. Here is a link to its webinar series.. https://www.fundamentalsurgery.com/about/events-webinars/ The really interesting part is from about 49 minutes in on the first webinar on the right. In particular this platform utilises haptic technology so this is what brought me back to 'good surgical feel' comment from the last RNS.
langland
03/5/2020
13:16
More anecdotal evidence that elective surgery will be resuming in the States. Hopefully, patients with cardiovascular issues will get some kind of priority. httpS://www.charlotteobserver.com/news/coronavirus/article242430496.html Introducing paragraph included: “ Other states like California, which has no expiration date on its current stay-at-home order, has said it will begin allowing “important medical procedures like heart surgery,” CNN reported.” This is hopeful news for RUA Medical’s main customer who presumably will need to start anticipating supplying countless hospitals facing a long backlog of cases.
bones
03/5/2020
13:03
Well said cfb2. Now where is Nicola Sturgeon with this positive data? It would be good to see her promoting Scottish enterprise for once instead of complaining about Westminster! 😁
bones
02/5/2020
16:52
As you say, a successful and profitable local business will repay the grant in taxes for years to come but more than that: Successful businesses tend to pull in talent from around the world, which in turn produces more successful businesses. Longer term the government hopes to become a hub for innovative technology. Incidentally, by insisting on joint funding, which was one of the terms of the investment, the Scottish government is relying on the scrutiny of a third party to reduce the risk. It adds credibility for the company if it has backing by the government when their products are exported worldwide. Free publicity for the company if there is a whiff of it becoming successful. If a politician believes they have done something good they'll be shouting it from the rooftops and they'll never shut up about it!
cfb2
02/5/2020
14:13
What benefit does the scottish gov get with the funding it has provided? Is it just helping the local business to become ultimately successful and become a job creator to further the economy?
nimbo10
29/4/2020
19:26
If it was me who had sold, I think I might have compounded my problem looking at the price now.
semper vigilans
29/4/2020
19:13
Nimbo, that was a sell for sure. The price puked at that moment yesterday with two MM’s reducing immediately to 60-70. I was watching the action yesterday at that time and could not figure the reason for the weakness but assumed a delayed sale which never materialised yesterday. Now we know. I guess the sale cleared a blockage and its been plain sailing since with no apparent overhang. I expect the seller had bills to pay or Covid stocks to punt?
bones
29/4/2020
18:08
Looks like uptick of 13p today, a substantial trade 36796 recorded yest at 9:13 at 65.25. As to a buy or sell can't tell, for holders moving in right direction.
nimbo10
29/4/2020
15:12
Placing not going to happen end of
cocker
29/4/2020
14:50
Agree no one wants to see a Placing and I have no information to say a Placing is in the offing. However these are difficult times for even the most well managed business. They have achieved a great deal on what is a shoestring budget. Clearly there will be delays entirely beyond their control and it is not clear how soon things will return to any sort of normal.
nextlink
29/4/2020
14:39
Nextlink. Not sure I want to see any kind of placing at these lowly prices. Company should be worth much more and then you might accept one to be fair to the investors. In any case, the company said the following just last month: ”The Board is taking prudent steps to mitigate and manage its cashflow and the agreement with David Richmond to defer part of the cash consideration is part of that exercise. The Board is confident that the Enlarged Group is well equipped and operating in an essential industry to enable both AorTech and RUA to withstand this near-term uncertainty.”
bones
29/4/2020
13:36
Fantastic Company with a great future. However Covid19 will have caused some disruption. Wondering if a modest Placing is in the offing.
nextlink
29/4/2020
13:32
Nimbo, Aortech said it’s down to Companies House getting their act together (skeleton staff scenario), so no guide date available. The sooner the better.
bones
29/4/2020
13:17
Anyone know What date is the name change?
nimbo10
29/4/2020
10:43
NY Boy, you will find that 676p is the new 400p! See Equity Development note here: Https://www.equitydevelopment.co.uk/edreader/?ltkn=%5BID%5D&d=%3D%3DQM5YjM (Just click the X if you get a dialog box to register, you don’t have to. Click X to see the whole 17 page report) ED followed up with an update after the RUA acquisition was announced, upping valuation to 689p: Https://equitydevelopment.co.uk/edreader/?d=%3D%3DgN5YjM
bones
29/4/2020
10:09
I have got a diary note 30 Nov 2023 to check for 400p 😁
ny boy
Chat Pages: 356  355  354  353  352  351  350  349  348  347  346  345  Older
ADVFN Advertorial
Your Recent History
LSE
AOR
Aortech
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200714 23:56:53